Aftermath Silver (TSXV:AAG) Closes $20 Million Private Placement

Vancouver, British Columbia — December 23, 2025 — Leads & Copy — Aftermath Silver Ltd. has closed a brokered private placement of 22,222,250 common shares, raising gross proceeds of $20,000,025.

The offering, led by Research Capital Corporation and Red Cloud Securities Inc., was completed under the listed issuer financing exemption.

Net proceeds will fund exploration and development at the Berenguela Silver-Copper-Manganese project in southern Peru, a pre-feasibility study for the project, further exploration at the company’s other mineral projects, and for working capital and general corporate purposes.

A related party of the company acquired 9,900,000 shares. The issuance of these securities is considered a related party transaction under TSXV Policy 5.9 and Multilateral Instrument 61-101. The company relied on exemptions from valuation and minority shareholder approval requirements as the fair market value of the securities did not exceed 25% of the company’s market capitalization.

The company paid the agents a cash commission of approximately $1,200,000 in connection with the offering, which is subject to final approval of the TSX Venture Exchange.

Aftermath Silver Ltd. is focused on silver and critical metals project acquisition and development. Its assets include:

  • Berenguela Silver-Copper-Manganese project in southern central Peru, with rights acquired through an agreement with SSR Mining and EMX Royalties. A current NI 43-101 mineral resource estimate was published on December 4, 2025, and a NI43-101Technical Report on the property will be filed shortly.
  • Challacollo Silver-Gold project, acquired from Mandalay Resources. A NI 43-101 mineral resource was released on December 15, 2020.
  • Cachinal Silver-Gold project, located south of Antofagasta.

Ralph Rushton, CEO and Director, can be reached at 604-484-7855.

Source: Aftermath Silver Ltd.

×

Welcome!

Biotech Reporter is the source most up-to-date real-time, direct-from-source News Tips and Story Leads.

By Subscribing you will receive Daily Biotech Update each day at 9:30 am ET (Market Open) in your inbox and you can unsubscribe any time.